Prevalence And Prognostic Value of (TILs) Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer Patients
(2022). Prevalence And Prognostic Value of (TILs) Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer Patients. EKB Journal Management System, 10(3), 191-197.
. "Prevalence And Prognostic Value of (TILs) Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer Patients". EKB Journal Management System, 10, 3, 2022, 191-197.
(2022). 'Prevalence And Prognostic Value of (TILs) Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer Patients', EKB Journal Management System, 10(3), pp. 191-197.
Prevalence And Prognostic Value of (TILs) Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer Patients. EKB Journal Management System, 2022; 10(3): 191-197.